DIVERSIFIED HEALTHCARE TRUST — Form 10-Q
Filed November 2, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
This excerpt contains only standard Sarbanes-Oxley certifications (Exhibits 31.1, 31.2, 32.1) signed by Christopher J. Bilotto (CEO) and Matthew C. Brown (CFO) on November 2, 2026. The certifications attest that the Q3 2026 10-Q contains no untrue material facts, that financial statements fairly present the company's condition, and that disclosure controls and internal controls over financial reporting are effective. No specific transactions, dollar amounts, counterparties, or operational changes are disclosed in this exhibit section.
Why this rating
Exhibit-only certifications are routine, mandatory regulatory filings with no business substance or disclosed changes. No material transactions or events disclosed.
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.